This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

trusted source


Using cryo-shocked tumor cells to fight lung cancer

Using cryo-shocked tumor cells to fight lung cancer
Schedule of LNT cells delivery of CRISPR-Cas9 nanoparticles for KRAS-mutant NSCLC treatment. Credit: Science Advances (2024). DOI: 10.1126/sciadv.adk8264

A team of medical researchers at Zhejiang University, in China, has developed a way to use cryo-shocked tumor cells to fight lung cancer. In their study, published in the journal Science Advances, the group used fast liquid nitrogen treatment to modify tumor cells to carry gene-editing tools to fight tumors in mouse models.

As noted by the researchers, CRISPR-mediated genome editing tools and techniques hold great promise for treating cancer. However, problems with tumor targeting and off-target side effects hamper their effectiveness. For this new research, the team found a way to improve targeting by converting into carriers for the gene editing tools.

The work involved cryo-shocking tumor cells extracted from a patient, which involved rapid freezing using liquid nitrogen. Such freezing removed their pathogenicity while preserving their structure, and more importantly, their surface receptor functions. After freezing, the CRISPR-Cas9 system was loaded into the cryo-shocked tumor cell, which made its way to the tumor, where it was ablated.

The team tested their approach by collecting tumor samples from mouse models, cryo-shocking the samples, loading them with the CRISPR-Cas9 system and then injecting them back into the mice. The treated tumor cells made their way to the tumor as hoped, where they released the CRISPR-Cas9 system, which in turn knocked down cyclin-dependent kinase 4, resulting in tumor cell death.

In comparing the approach to simply injecting the CRISPR-Cas9 system into tumors, the research team found that the newer approach offered greater lethality. The improvement, they found, was due to greater accuracy in targeting. The deactivated tumor cells were drawn to the tumor, where they bonded with the active tumor cells via cell receptors, giving the gene editing system to . The approach also prevented the gene editing system from working on noncancerous cells.

The research team noted also that freezing cancer cells using allowed the cells to retain their antigens, which they suggest could prove useful in developing a vaccine as part of cancer treatment.

More information: Feng Liu et al, Cryo-shocked tumor cells deliver CRISPR-Cas9 for lung cancer regression by synthetic lethality, Science Advances (2024). DOI: 10.1126/sciadv.adk8264

Journal information: Science Advances

© 2024 Science X Network

Citation: Using cryo-shocked tumor cells to fight lung cancer (2024, April 1) retrieved 23 April 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

A nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment


Feedback to editors